Evaluation of insulin-like growth factor-I in postmenopausal women with breast cancer treated with raloxifene

about

Estrogens and selective estrogen receptor modulators in acromegaly.Estrogen and selective estrogen receptor modulators (SERMs) for the treatment of acromegaly: a meta-analysis of published observational studies.

P2860

Q34541969-767F5383-73E9-4055-988D-AFE9804ACC1A Q38127391-799870D8-8459-4B96-AF60-3D6420DDE09F

P2860

Evaluation of insulin-like growth factor-I in postmenopausal women with breast cancer treated with raloxifene

Item

http://www.wikidata.org/entity/Q35933230

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Evaluation of insulin-like gro ...... cancer treated with raloxifene

@ast

Evaluation of insulin-like gro ...... cancer treated with raloxifene

@en

type

Item

label

Evaluation of insulin-like gro ...... cancer treated with raloxifene

@ast

Evaluation of insulin-like gro ...... cancer treated with raloxifene

@en

prefLabel

Evaluation of insulin-like gro ...... cancer treated with raloxifene

@ast

Evaluation of insulin-like gro ...... cancer treated with raloxifene

@en

P1476

Evaluation of insulin-like gro ...... cancer treated with raloxifene

@en

P2093

Alesse R dos Santos

http://www.w3.org/2001/XMLSchema#string

Benedito B da Silva

http://www.w3.org/2001/XMLSchema#string

Cleicilene G Pires

http://www.w3.org/2001/XMLSchema#string

Daniel S Moita

http://www.w3.org/2001/XMLSchema#string

Edílson C Sousa-Junior

http://www.w3.org/2001/XMLSchema#string

Pedro V Lopes-Costa

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

IGF status is altered by tamoxifen in patients with breast cancer.

Effect of raloxifene on IGF-I and IGFBP-3 in postmenopausal women with breast cancer

The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women

Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis.

Tamoxifen for the prevention of breast cancer.

Tamoxifen inhibits angiogenesis in estrogen receptor-negative animal models.

Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia.

The GH-IGF-I axis and breast cancer.

P2888

1477-7800-4-18

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1477-7800-4-18

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2007-07-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6192441

http://www.w3.org/2001/XMLSchema#string

P6179

1024554818

http://www.w3.org/2001/XMLSchema#string

P698

17645796

http://www.w3.org/2001/XMLSchema#string

P932

1945022

http://www.w3.org/2001/XMLSchema#string

Evaluation of insulin-like growth factor-I in postmenopausal women with breast cancer treated with raloxifene

about

P2860

P2860

Evaluation of insulin-like growth factor-I in postmenopausal women with breast cancer treated with raloxifene

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P577

P5875

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P577

P5875

P6179

P698

P932